Literature DB >> 18784269

Analysis of overridden alerts in a drug-drug interaction detection system.

Frédéric Mille1, Céline Schwartz, Francoise Brion, Jean-Eudes Fontan, Olivier Bourdon, Patrice Degoulet, Marie-Christine Jaulent.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the relevance of the signals generated by a computerized drug-drug interaction detection system and to design a classification of overridden drug-drug interaction alerts. STUDY
DESIGN: Prospective study over two months.
SETTING: Five hundred and ten-bed university paediatric hospital. MAIN OUTCOME MEASURES: In Robert Debré Hospital physicians generate drug orders online using a computerized physician order entry system that also detects drug-drug interactions in real time. We analysed the relevance of a sample of alerts overridden by physicians.
RESULTS: We analysed a sample of 613 overridden alerts. We defined three categories of overridden alerts: informational errors (35); system errors (244) and accurate alerts (334). Two reasons account for 40% of false-positive alerts: an inability of the system to recognize real conflicts between drug treatments and guidelines stating that the two drugs can be used together, because the benefit outweighs the risk of side effects due to the drug-drug interaction.
CONCLUSIONS: We created a classification of overridden alerts, in the context of computerized physician order entry system coupled with a drug-drug interaction detection system. There is clearly room for improvement in the development of drug-drug interaction software. This classification should make it possible to break this work down into smaller tasks, making it possible to decrease the sensitivity to background noise of drug-drug interaction detection systems.

Mesh:

Year:  2008        PMID: 18784269     DOI: 10.1093/intqhc/mzn038

Source DB:  PubMed          Journal:  Int J Qual Health Care        ISSN: 1353-4505            Impact factor:   2.038


  12 in total

1.  Integration of heterogeneous clinical decision support systems and their knowledge sets: feasibility study with Drug-Drug Interaction alerts.

Authors:  Hye Jin Kam; Jeong Ah Kim; InSook Cho; Yoon Kim; Rae Woong Park
Journal:  AMIA Annu Symp Proc       Date:  2011-10-22

2.  Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy.

Authors:  Roberto Leone; Lara Magro; Ugo Moretti; Paola Cutroneo; Martina Moschini; Domenico Motola; Marco Tuccori; Anita Conforti
Journal:  Drug Saf       Date:  2010-08-01       Impact factor: 5.606

3.  [Validation of interaction databases in psychopharmacotherapy].

Authors:  M Hahn; S C Roll
Journal:  Nervenarzt       Date:  2018-03       Impact factor: 1.214

4.  An evaluation of the completeness of drug-drug interaction-related information in package inserts.

Authors:  Giok Qin Ng; Grant Edward Sklar; Hui Ting Chng
Journal:  Eur J Clin Pharmacol       Date:  2016-10-29       Impact factor: 2.953

5.  Drug interactions in dying patients: a retrospective analysis of hospice inpatients in Germany.

Authors:  Sebastian Frechen; Anna Zoeller; Klaus Ruberg; Raymond Voltz; Jan Gaertner
Journal:  Drug Saf       Date:  2012-09-01       Impact factor: 5.606

6.  Electronic prescribing increases uptake of clinical pharmacologists' recommendations in the hospital setting.

Authors:  Anne B Taegtmeyer; Ivanka Curkovic; Kaspar Rufibach; Natascia Corti; Edouard Battegay; Gerd A Kullak-Ublick
Journal:  Br J Clin Pharmacol       Date:  2011-12       Impact factor: 4.335

7.  Nationwide drug-dispensing data reveal important differences in adherence to drug label recommendations on CYP2D6-dependent drug interactions.

Authors:  Buster Mannheimer; Björn Wettermark; Michael Lundberg; Hans Pettersson; Christer von Bahr; Erik Eliasson
Journal:  Br J Clin Pharmacol       Date:  2010-04       Impact factor: 4.335

8.  Physicians' responses to computerized drug interaction alerts with password overrides.

Authors:  Yasuyuki Nasuhara; Ken Sakushima; Akira Endoh; Reona Umeki; Hiromitsu Oki; Takehiro Yamada; Ken Iseki; Makoto Ishikawa
Journal:  BMC Med Inform Decis Mak       Date:  2015-08-28       Impact factor: 2.796

Review 9.  Criteria for assessing high-priority drug-drug interactions for clinical decision support in electronic health records.

Authors:  Shobha Phansalkar; Amrita Desai; Anish Choksi; Eileen Yoshida; John Doole; Melissa Czochanski; Alisha D Tucker; Blackford Middleton; Douglas Bell; David W Bates
Journal:  BMC Med Inform Decis Mak       Date:  2013-06-13       Impact factor: 2.796

10.  Differences of Reasons for Alert Overrides on Contraindicated Co-prescriptions by Admitting Department.

Authors:  Eun Kyoung Ahn; Soo-Yeon Cho; Dahye Shin; Chul Jang; Rae Woong Park
Journal:  Healthc Inform Res       Date:  2014-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.